These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9430241)

  • 1. X-linked hypophosphatemia: normal renal function despite medullary nephrocalcinosis 25 years after transient vitamin D2-induced renal azotemia.
    Eddy MC; McAlister WH; Whyte MP
    Bone; 1997 Dec; 21(6):515-20. PubMed ID: 9430241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperoxaluria is not a cause of nephrocalcinosis in phosphate-treated patients with hereditary hypophosphatemic rickets.
    Tieder M; Blonder J; Strauss S; Shaked U; Maor J; Gabizon D; Manor H; Sela BA
    Nephron; 1993; 64(4):526-31. PubMed ID: 8396209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked hypophosphatemic rickets and nephrocalcinosis: clinical characteristics of a single-center pediatric cohort in North America before and after burosumab.
    Paloian NJ; Boyke-Lohmann LR; Steiner RD
    Front Pediatr; 2024; 12():1430921. PubMed ID: 39156019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal study.
    Portale AA; Ward L; Dahir K; Florenzano P; Ing SW; Jan de Beur SM; Martin RM; Meza-Martinez AI; Paloian N; Ashraf A; Dixon BP; Khan A; Langman C; Chen A; Wang C; Roberts MS; Tandon PK; Bedrosian C; Imel EA
    J Bone Miner Res; 2024 Sep; 39(10):1493-1502. PubMed ID: 39151033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final height of Japanese patients with X-linked hypophosphatemic rickets: effect of vitamin D and phosphate therapy.
    Miyamoto J; Koto S; Hasegawa Y
    Endocr J; 2000 Apr; 47(2):163-7. PubMed ID: 10943740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrocalcinosis and its relationship to treatment of hereditary rickets.
    Goodyer PR; Kronick JB; Jequier S; Reade TM; Scriver CR
    J Pediatr; 1987 Nov; 111(5):700-4. PubMed ID: 2822887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets.
    Reusz GS; Latta K; Hoyer PF; Byrd DJ; Ehrich JH; Brodehl J
    Lancet; 1990 May; 335(8700):1240-3. PubMed ID: 1971321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrocalcinosis is associated with renal tubular acidosis in children with X-linked hypophosphatemia.
    Seikaly M; Browne R; Baum M
    Pediatrics; 1996 Jan; 97(1):91-3. PubMed ID: 8545232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia.
    Seikaly MG; Brown R; Baum M
    Pediatrics; 1997 Nov; 100(5):879-84. PubMed ID: 9346990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dipyridamole on serum and urinary phosphate in X-linked hypophosphatemia.
    Seikaly MG; Quigley R; Baum M
    Pediatr Nephrol; 2000 Nov; 15(1-2):57-9. PubMed ID: 11095012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrocalcinosis in X-linked hypophosphataemic rickets: its relationship to treatment, kidney function, and growth.
    Kooh SW; Binet A; Daneman A
    Clin Invest Med; 1994 Apr; 17(2):123-30. PubMed ID: 8004848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular abnormalities in patients with X-linked hypophosphatemia.
    Nehgme R; Fahey JT; Smith C; Carpenter TO
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2450-4. PubMed ID: 9253316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrocalcinosis in X-linked hypophosphatemia: effect of treatment versus disease.
    Taylor A; Sherman NH; Norman ME
    Pediatr Nephrol; 1995 Apr; 9(2):173-5. PubMed ID: 7794712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocytosis in hypophosphatemic rickets: irreversible complication due to nephrocalcinosis after vitamin D and phosphate therapy.
    Okazaki R; Matsumoto T; Harada S; Fukomoto S; Motokura T; Ogata E
    Jpn J Med; 1991; 30(6):545-7. PubMed ID: 1665879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis.
    Reusz GS; Hoyer PF; Lucas M; Krohn HP; Ehrich JH; Brodehl J
    Arch Dis Child; 1990 Oct; 65(10):1125-8. PubMed ID: 2248503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic advances, biochemical and clinical features and critical approach to treatment of patients with X-linked hypophosphatemic rickets.
    Baroncelli GI; Bertelloni S; Sodini F; Galli L; Vanacore T; Fiore L; Saggese G
    Pediatr Endocrinol Rev; 2004 Jun; 1(4):361-79. PubMed ID: 16437029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity.
    Lyles KW; Drezner MK
    J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guide-lines to the treatment of patients with X-linked hypophosphatemic rickets.
    Reusz GS
    Acta Biomed Ateneo Parmense; 1995; 66(3-4):147-51. PubMed ID: 8578931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension in hypophosphatemic rickets--role of secondary hyperparathyroidism.
    Alon US; Monzavi R; Lilien M; Rasoulpour M; Geffner ME; Yadin O
    Pediatr Nephrol; 2003 Feb; 18(2):155-8. PubMed ID: 12579406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.